CADL

Candel Therapeutics INC

+$79.9M

Net Activity

Institutions Holding

115

Popularity Rank

#4162

Avg Weight

0.11%

Total Value

$215.4M

Ownership Trend

115 institutions currently hold CADL, with 77 net buyers and 29 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

29

Net Buying Institutions

77

Key Holders

View all 115 holding institutions

Quarterly Activity

Recent Activity

+$193.9M

Total Buy Value

$7.6M

Total Sell Value

New buy35
Trim22
Add42
Sold out7

77

Net Buyers

29

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

2

Filings (90d)

$298K

Total Est. Value

30K shares

Planned Shares

Last Filed 2026-06-29
FilerFiling DateEst. Value
Tyagarajan Seshu2026-06-29$69K
Barone Francesca2026-06-29$230K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding CANDEL THERAPEUTICS INC (CADL)?
Major stakeholders currently include FMR LLC ($53.8M), Rtw Investments, LP ($31.5M), Acorn Capital Advisors, LLC ($17.2M). Based on the latest 13F filings, there are a total of 115 tracked investment funds and institutions maintaining positions in CADL.
What is the overall institutional sentiment toward CADL recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $79.9M, driven by 77 managers accumulating shares while 29 reduced their exposure.
Which institutions have been selling or reducing their CADL positions?
In the latest period, 22 funds trimmed their holdings, and 7 managers completely exited their positions. The aggregate reported sell value was $7.6M.
Are there any notable investors adding CADL to their portfolios?
Yes, buying activity remains notable. 35 institutions opened new positions in {ticker}, and 42 existing holders added to their shares. The total reported buy value for the quarter amounted to $193.9M.

Related Stocks